Takara Bio Inc.
Investor Relations
Financial Data
Financial Highlights（Quarterly）

Financial Highlights（Quarterly）

Financial Highlights（Quarterly）

Net Sales

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	34,565	46,086	67,699	78,142	43,505	45,039
3Q	24,558	29,549	45,659	60,206	29,734	29,282
2Q	16,450	17,393	31,551	32,587	19,116	19,758
1Q	8,650	6,938	15,272	14,102	9,176	8,493

Operating Income

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	6,274	13,952	28,902	20,541	3,003	2,263
3Q	3,879	8,791	19,926	19,403	336	-1,473
2Q	3,035	3,736	14,105	10,870	1,410	417
1Q	2,251	693	8,504	4,537	423	-1,634

Ordinary Income

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	6,347	14,159	28,459	20,682	3,405	2,592
3Q	3,896	8,919	20,154	19,480	586	-1,255
2Q	2,961	3,820	14,241	10,955	1,598	549
1Q	2,200	745	8,579	4,593	509	-1,498

Profit Attributable to Owners of Parent

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	3,819	9,547	19,849	16,012	1,480	1,041
3Q	2,708	5,726	14,364	14,595	154	-1,378
2Q	2,075	2,274	10,009	8,538	1,084	513
1Q	1,591	404	6,025	3,907	319	-1,047

Net Income Per Share

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	31.72	79.29	164.84	132.97	12.30	8.65
3Q	22.49	47.56	119.29	121.21	1.28	-11.45
2Q	17.23	18.89	83.12	70.91	9.00	4.26
1Q	13.22	3.36	50.04	32.45	2.65	-8.70

Total Assets

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	75,009	89,750	115,712	129,202	121,252	125,334
3Q	71,835	83,846	106,116	128,140	123,087	119,301
2Q	70,837	77,343	104,777	120,023	123,283	125,280
1Q	71,402	73,593	99,658	111,488	120,662	121,752

Net Assets

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	66,591	74,302	96,064	112,454	111,784	115,849
3Q	64,888	70,568	89,455	114,711	112,529	109,003
2Q	64,558	67,236	84,766	106,949	112,130	116,155
1Q	65,154	65,580	80,586	98,425	108,207	111,516

Capital Adequacy Ratio

	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
FY	88.7	82.7	82.9	86.9	92.0	92.2
3Q	90.2	84.0	84.1	89.3	91.2	91.1
2Q	91.0	86.8	80.7	88.9	90.7	92.4
1Q	91.1	89.0	80.7	88.1	89.5	91.3

CLOSE
MENU

サイト内検索

footer-content

menu

JA
EN

contact

gnavi-box